S&P 500   4,562.60 (-0.10%)
DOW   36,132.43 (+0.02%)
QQQ   387.12 (-0.04%)
AAPL   192.87 (-0.28%)
MSFT   369.14 (-0.91%)
META   320.17 (+0.59%)
GOOGL   130.78 (-0.16%)
AMZN   146.04 (-0.57%)
TSLA   245.18 (+2.71%)
NVDA   463.11 (-0.55%)
NIO   8.02 (+7.94%)
BABA   72.16 (-0.30%)
AMD   119.43 (+0.89%)
T   16.98 (-1.39%)
F   10.80 (+1.89%)
MU   73.74 (+0.07%)
CGC   0.68 (+2.72%)
GE   120.64 (+0.34%)
DIS   92.01 (+1.34%)
AMC   6.98 (-0.57%)
PFE   29.18 (+0.31%)
PYPL   60.05 (+3.68%)
XOM   98.50 (-1.93%)
S&P 500   4,562.60 (-0.10%)
DOW   36,132.43 (+0.02%)
QQQ   387.12 (-0.04%)
AAPL   192.87 (-0.28%)
MSFT   369.14 (-0.91%)
META   320.17 (+0.59%)
GOOGL   130.78 (-0.16%)
AMZN   146.04 (-0.57%)
TSLA   245.18 (+2.71%)
NVDA   463.11 (-0.55%)
NIO   8.02 (+7.94%)
BABA   72.16 (-0.30%)
AMD   119.43 (+0.89%)
T   16.98 (-1.39%)
F   10.80 (+1.89%)
MU   73.74 (+0.07%)
CGC   0.68 (+2.72%)
GE   120.64 (+0.34%)
DIS   92.01 (+1.34%)
AMC   6.98 (-0.57%)
PFE   29.18 (+0.31%)
PYPL   60.05 (+3.68%)
XOM   98.50 (-1.93%)
S&P 500   4,562.60 (-0.10%)
DOW   36,132.43 (+0.02%)
QQQ   387.12 (-0.04%)
AAPL   192.87 (-0.28%)
MSFT   369.14 (-0.91%)
META   320.17 (+0.59%)
GOOGL   130.78 (-0.16%)
AMZN   146.04 (-0.57%)
TSLA   245.18 (+2.71%)
NVDA   463.11 (-0.55%)
NIO   8.02 (+7.94%)
BABA   72.16 (-0.30%)
AMD   119.43 (+0.89%)
T   16.98 (-1.39%)
F   10.80 (+1.89%)
MU   73.74 (+0.07%)
CGC   0.68 (+2.72%)
GE   120.64 (+0.34%)
DIS   92.01 (+1.34%)
AMC   6.98 (-0.57%)
PFE   29.18 (+0.31%)
PYPL   60.05 (+3.68%)
XOM   98.50 (-1.93%)
S&P 500   4,562.60 (-0.10%)
DOW   36,132.43 (+0.02%)
QQQ   387.12 (-0.04%)
AAPL   192.87 (-0.28%)
MSFT   369.14 (-0.91%)
META   320.17 (+0.59%)
GOOGL   130.78 (-0.16%)
AMZN   146.04 (-0.57%)
TSLA   245.18 (+2.71%)
NVDA   463.11 (-0.55%)
NIO   8.02 (+7.94%)
BABA   72.16 (-0.30%)
AMD   119.43 (+0.89%)
T   16.98 (-1.39%)
F   10.80 (+1.89%)
MU   73.74 (+0.07%)
CGC   0.68 (+2.72%)
GE   120.64 (+0.34%)
DIS   92.01 (+1.34%)
AMC   6.98 (-0.57%)
PFE   29.18 (+0.31%)
PYPL   60.05 (+3.68%)
XOM   98.50 (-1.93%)

TerrAscend (TRSSF) Stock Forecast & Price Target

$1.56
-0.03 (-1.89%)
(As of 12/5/2023 ET)
Compare
Today's Range
$1.53
▼
$1.60
50-Day Range
$1.49
▼
$2.06
52-Week Range
$1.62
▼
$1.80
Volume
237,478 shs
Average Volume
131,026 shs
Market Capitalization
$392.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.88
Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest

TerrAscend Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 3 Analyst Ratings

Analysts' Consensus Price Target

$1.75
12.18% Upside
High Forecast$1.75
Average Forecast$1.75
Low Forecast$1.75
TypeCurrent Forecast
12/6/22 to 12/6/23		1 Month Ago
11/6/22 to 11/6/23		3 Months Ago
9/7/22 to 9/7/23		1 Year Ago
12/6/21 to 12/6/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$1.75$1.75$1.95$2.91
Predicted Upside12.18% Upside18.24% Upside23.22% Upside40.66% Upside
Get TerrAscend Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TRSSF and its competitors with MarketBeat's FREE daily newsletter.


TRSSF Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TRSSF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

TerrAscend Stock vs. The Competition

TypeTerrAscendMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.67
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside12.18% Upside670.72% Upside2,089.06% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/4/2023Atb Cap Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		F. Gomes
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOutperform
6/30/2023Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeHold ➝ Buy
5/19/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Hold
2/8/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetC$5.50 ➝ C$4.50

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:58 PM ET.












TRSSF Price Target - Frequently Asked Questions

What is TerrAscend's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for TerrAscend stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for TRSSF. The average twelve-month price prediction for TerrAscend is $1.75 with a high price target of $1.75 and a low price target of $1.75. Learn more on TRSSF's analyst rating history.

Do Wall Street analysts like TerrAscend more than its competitors?

Analysts like TerrAscend less than other Medical companies. The consensus rating score for TerrAscend is 2.67 while the average consensus rating score for medical companies is 2.67. Learn more on how TRSSF compares to other companies.

Does TerrAscend's stock price have much upside?

According to analysts, TerrAscend's stock has a predicted upside of 18.24% based on their 12-month stock forecasts.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (OTCMKTS:TRSSF) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -